These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34066322)

  • 1. CD4
    Buschow SI; Jansen DTSL
    Cells; 2021 May; 10(5):. PubMed ID: 34066322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological cure of HBV infection.
    Lang J; Neumann-Haefelin C; Thimme R
    Hepatol Int; 2019 Mar; 13(2):113-124. PubMed ID: 30600480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen.
    Lau GK; Suri D; Liang R; Rigopoulou EI; Thomas MG; Mullerova I; Nanji A; Yuen ST; Williams R; Naoumov NV
    Gastroenterology; 2002 Mar; 122(3):614-24. PubMed ID: 11874993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of HBV-Specific CD8
    Heim K; Neumann-Haefelin C; Thimme R; Hofmann M
    Front Immunol; 2019; 10():2240. PubMed ID: 31620140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OX40 stimulation and PD-L1 blockade synergistically augment HBV-specific CD4 T cells in patients with HBeAg-negative infection.
    Jacobi FJ; Wild K; Smits M; Zoldan K; Csernalabics B; Flecken T; Lang J; Ehrenmann P; Emmerich F; Hofmann M; Thimme R; Neumann-Haefelin C; Boettler T
    J Hepatol; 2019 Jun; 70(6):1103-1113. PubMed ID: 30826436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrepant Clinical Significance of CD28
    Shen XH; Xu P; Yu X; Song HF; Chen H; Zhang XG; Wu MY; Wang XF
    Viral Immunol; 2018 Oct; 31(8):548-558. PubMed ID: 30117787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patients.
    Dou Y; Jansen DTSL; van den Bosch A; de Man RA; van Montfoort N; Araman C; van Kasteren SI; Zom GG; Krebber WJ; Melief CJM; Woltman AM; Buschow SI
    Antiviral Res; 2020 Jun; 178():104746. PubMed ID: 32081741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection.
    Franzese O; Kennedy PT; Gehring AJ; Gotto J; Williams R; Maini MK; Bertoletti A
    J Virol; 2005 Mar; 79(6):3322-8. PubMed ID: 15731226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell receptor grafting allows virological control of Hepatitis B virus infection.
    Wisskirchen K; Kah J; Malo A; Asen T; Volz T; Allweiss L; Wettengel JM; Lütgehetmann M; Urban S; Bauer T; Dandri M; Protzer U
    J Clin Invest; 2019 Apr; 129(7):2932-2945. PubMed ID: 31039136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of CD25+CD4+T cells (Tregs) enhances the HBV-specific CD8+ T cell response primed by DNA immunization.
    Furuichi Y; Tokuyama H; Ueha S; Kurachi M; Moriyasu F; Kakimi K
    World J Gastroenterol; 2005 Jun; 11(24):3772-7. PubMed ID: 15968737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of immunomodulatory therapy (other than interferon) for the treatment of chronic hepatitis B virus infection.
    Lau GK
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E46-52. PubMed ID: 10921382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell immunopathogenesis and immunotherapeutic strategies for chronic hepatitis B virus infection.
    Shimizu Y
    World J Gastroenterol; 2012 May; 18(20):2443-51. PubMed ID: 22654441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HBcAg-specific IL-21-producing CD4+ T cells are associated with relative viral control in patients with chronic hepatitis B.
    Li L; Liu M; Cheng LW; Gao XY; Fu JJ; Kong G; Feng X; Pan XC
    Scand J Immunol; 2013 Nov; 78(5):439-46. PubMed ID: 23957859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-21 responses in patients with chronic hepatitis B.
    Li J; Ren W; Ma W; Zhang J; Shi J; Qin C
    J Interferon Cytokine Res; 2015 Feb; 35(2):134-42. PubMed ID: 25243706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of interleukin-21 in HBV infection: friend or foe?
    Li Y; Tang L; Hou J
    Cell Mol Immunol; 2015 May; 12(3):303-8. PubMed ID: 25363528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B.
    Boni C; Penna A; Bertoletti A; Lamonaca V; Rapti I; Missale G; Pilli M; Urbani S; Cavalli A; Cerioni S; Panebianco R; Jenkins J; Ferrari C
    J Hepatol; 2003 Oct; 39(4):595-605. PubMed ID: 12971971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
    Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
    J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection.
    Wang H; Luo H; Wan X; Fu X; Mao Q; Xiang X; Zhou Y; He W; Zhang J; Guo Y; Tan W; Deng G
    J Hepatol; 2020 Jan; 72(1):45-56. PubMed ID: 31499130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-35 expression in peripheral blood CD4(+) T cells from chronic hepatitis B virus-infected patients directly correlates with virus load.
    Zhou Y; Zhang H; Li Y
    Cytokine; 2015 May; 73(1):169-75. PubMed ID: 25752977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Highly Attenuated Vesicular Stomatitis Virus-Based Vaccine Platform Controls Hepatitis B Virus Replication in Mouse Models of Hepatitis B.
    Moshkani S; Chiale C; Lang SM; Rose JK; Robek MD
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.